This topic contains a solution. Click here to go to the answer

Author Question: Homo ergaster has been proposed to A) replace the name of some of the Homo erectus fossils in ... (Read 71 times)

s.tung

  • Hero Member
  • *****
  • Posts: 577
Homo ergaster has been proposed to
 
  A) replace the name of some of the Homo erectus fossils in Africa
  B) explain the lack of Asian H. erectus trait in H. heidelburgensis
  C) name such fossils as KNM ER-3733, KNM-ER3883 and KNM WT-15000
  D) name the fossils that have been recovered from Lake Turkana
  E) all of the above

Question 2

Ronald Fisher's mathematical analyses showed that
 
  A) variation within populations disappears over time
  B) Mendel's Principle of Segregation was in error
  C) mimics could be matched to models only through mutations
  D) natural selection acting on small variations could match mimic to model
  E) mutations have little effect on genetic variance in a species



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shailee

  • Sr. Member
  • ****
  • Posts: 392
Answer to Question 1

E

Answer to Question 2

D




s.tung

  • Member
  • Posts: 577
Reply 2 on: Aug 11, 2018
Great answer, keep it coming :)


emsimon14

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Excellent

 

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library